KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Inventory: 2009-2025

Historic Inventory for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $391.6 million.

  • Idexx Laboratories' Inventory rose 0.45% to $391.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.6 million, marking a year-over-year increase of 0.45%. This contributed to the annual value of $381.9 million for FY2024, which is 0.42% up from last year.
  • Idexx Laboratories' Inventory amounted to $391.6 million in Q3 2025, which was down 0.26% from $392.6 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Inventory peaked at $396.0 million during Q1 2025, and registered a low of $225.6 million during Q1 2021.
  • Its 3-year average for Inventory is $389.3 million, with a median of $391.0 million in 2023.
  • Per our database at Business Quant, Idexx Laboratories' Inventory spiked by 37.77% in 2022 and then declined by 3.84% in 2024.
  • Over the past 5 years, Idexx Laboratories' Inventory (Quarterly) stood at $269.0 million in 2021, then surged by 36.72% to $367.8 million in 2022, then climbed by 3.39% to $380.3 million in 2023, then grew by 0.42% to $381.9 million in 2024, then increased by 0.45% to $391.6 million in 2025.
  • Its Inventory was $391.6 million in Q3 2025, compared to $392.6 million in Q2 2025 and $396.0 million in Q1 2025.